Korean J Urol.  2010 Nov;51(11):737-744.

Current Laser Treatments for Benign Prostatic Hyperplasia

• Son H
• Song SH
• Paick JS

Abstract

The latest technical improvements in the surgical armamentarium are remarkable. In particular, advancements in the urologic field are so exceptional that we could observe the flare-up of robot-assisted laparoscopic radical prostatectomy for prostate cancer and laser prostatectomy for benign prostatic hyperplasia (BPH). Photoselective vaporization of the prostate (PVP) and holmium laser prostatectomy are the most generalized options for laser surgery of BPH, and both modalities have shown good postoperative results. In comparison to transurethral prostatectomy (TURP), they showed similar efficacy and a much lower complication rate in randomized prospective clinical trials. Even in cases of large prostates, laser prostatectomy showed comparable efficacy and safety profiles compared to open prostatectomy. From a technical point of view, PVP is considered to be an easier technique for the urologist to master. Furthermore, patients can be safely followed up in an outpatient clinic. Holmium laser enucleation of the prostate (HoLEP) mimics open prostatectomy because the adenomatous tissue is peeled off the surgical capsule in both procedures. Therefore, HoLEP shows notable volume reduction of the prostate similar to open prostatectomy with fewer blood transfusions, shorter hospital stay, and cost reduction regardless of prostate size. Outcomes of laser prostatectomy for BPH are encouraging but sometimes are unbalanced because safety and feasibility studies were reported mainly for PVP, whereas long-term data are mostly available for HoLEP. We need longer-term randomized clinical data to identify the reoperation rate of PVP and to determine which procedure is the ideal alternative to TURP and open prostatectomy for each patient.

Keyword

Laser therapy; Prostatic hyperplasia; Solid-state lasers

MeSH Terms

Ambulatory Care Facilities
Blood Transfusion
Humans
Laser Therapy
Lasers, Solid-State
Length of Stay
Prostate
Prostatectomy
Prostatic Hyperplasia
Prostatic Neoplasms
Reoperation
Transurethral Resection of Prostate
Volatilization

Reference

1. Mebust WK, Holtgrewe HL, Cockett AT, Peters PC. Transurethral prostatectomy: immediate and postoperative complications. A cooperative study of 13 participating institutions evaluating 3,885 patients. J Urol. 1989. 141:243–247.

2. Reich O, Bachmann A, Schneede P, Zaak D, Sulser T, Hofstetter A. Experimental comparison of high power (80 W) potassium titanyl phosphate laser vaporization and transurethral resection of the prostate. J Urol. 2004. 171:2502–2504.

3. Kuntz RM. Laser treatment of benign prostatic hyperplasia. World J Urol. 2007. 25:241–247.

4. Kang HW, Jebens D, Malek RS, Mitchell G, Koullick E. Laser vaporization of bovine prostate: a quantitative comparison of potassium-titanyl-phosphate and lithium triborate lasers. J Urol. 2008. 180:2675–2680.

5. Malek RS, Barrett DM, Kuntzman RS. High-power potassium-titanyl-phosphate (KTP/532) laser vaporization prostatectomy: 24 hours later. Urol. 1998. 51:254–256.

6. Park JH, Son H, Paick JS. Comparative analysis of the efficacy and safety of photoselective vaporization of the prostate for treatment of benign prostatic hyperplasia according to prostate size. Korean J Urol. 2010. 51:115–121.

7. Kauffman EC, Kang HW, Choi BB. The effect of laser-fiber sweeping speed on the efficiency of photoselective vaporization of the prostate in an ex vivo bovine model. J Endourol. 2009. 23:1429–1435.

8. Hoekstra RJ, van Melick HH, Kok ET, Ruud Bosch JL. A 10-year follow-up after transurethral resection of the prostate, contact laser prostatectomy and electrovaporization in men with benign prostatic hyperplasia; long-term results of a randomized controlled trial. BJU Int. 2010. 106:822–826.

9. Ku JH, Cho JY, Cho SY, Kim SW, Paick JS. The one year outcome after KTP laser vaporization of the prostate according to the calculated vaporized volume. J Korean Med Sci. 2009. 24:1187–1191.

10. Alivizatos G, Skolarikos A. Greenlight laser in benign prostatic hyperplasia: turning green into gold. Curr Opin Urol. 2008. 18:46–49.

11. Sulser T, Reich O, Wyler S, Ruszat R, Casella R, Hofstetter A, et al. Photoselective KTP laser vaporization of the prostate: first experiences with 65 procedures. J Endourol. 2004. 18:976–981.

12. Choo SH, Han DH, Lee SW. The efficacy and safety of KTP photoselective vaporization of the prostate for the treatment of benign prostatic hyperplasia: the 2-year results. Korean J Urol. 2008. 49:831–836.

13. Lee J, Kang SH, Kim JJ. Evaluation of the quality of life and the efficacy of treatment after high power potassium-titanyl-phosphate (KTP) laser vaporization for patients with a prostate volume greater than 40cc. Korean J Urol. 2007. 48:956–964.

14. Hwang CH, Cho CK, Lee YK, Hong SJ. Comparative analysis of short-term efficacy and complication of photoselective vaporization for benign prostatic hyperplasia which was classified by prostate size. Korean J Urol. 2007. 48:826–831.

15. Hwang EC, Joo JS, Min KD, Oh BR, Kang TW, Kwon DD, et al. A short-term comparative study on efficacy and safety of standard transurethral resection and high power (80W) potassium-titanyl-phosphate laser vaporization of the prostate. Korean J Urol. 2005. 46:1251–1255.

16. Rajbabu K, Chandrasekara SK, Barber NJ, Walsh K, Muir GH. Photoselective vaporization of the prostate with the potassium-titanyl-phosphate laser in men with prostates of >100 mL. BJU Int. 2007. 100:593–598.

17. Pfitzenmaier J, Gilfrich C, Pritsch M, Herrmann D, Buse S, Haferkamp A, et al. Vaporization of prostates of > or =80 mL using a potassium-titanyl-phosphate laser: midterm-results and comparison with prostates of <80 mL. BJU Int. 2008. 102:322–327.

18. Sandhu JS, Ng CK, Gonzalez RR, Kaplan SA, Te AE. Photoselective laser vaporization prostatectomy in men receiving anticoagulants. J Endourol. 2005. 19:1196–1198.

19. Fu WJ, Hong BF, Wang XX, Yang Y, Cai W, Gao JP, et al. Evaluation of greenlight photoselective vaporization of the prostate for the treatment of high-risk patients with benign prostatic hyperplasia. Asian J Androl. 2006. 8:367–371.

20. Reich O, Bachmann A, Siebels M, Hofstetter A, Stief CG, Sulser T. High power (80 W) potassium-titanyl-phosphate laser vaporization of the prostate in 66 high risk patients. J Urol. 2005. 173:158–160.

21. Heinrich E, Schiefelbein F, Schoen G. Technique and short-term outcome of green light laser (KTP, 80W) vaporization of the prostate. Eur Urol. 2007. 52:1632–1637.

22. Son H, Ro YK, Min SH, Choo MS, Kim JK, Lee CJ. Modified vaporization-resection for photoselective vaporization of the prostate using a greenlight™ high performance system 120W laser : the Seoul Technique. Urology. 2010. Epub ahead of print.

23. Araki M, Lam PN, Wong C. High-power potassium-titanyl-phosphate laser photoselective vaporization prostatectomy for symptomatic benign prostatic hyperplasia. J Endourol. 2008. 22:1311–1314.

24. Te AE, Malloy TR, Stein BS, Ulchaker JC, Nseyo UO, Hai MA, et al. Photoselective vaporization of the prostate for the treatment of benign prostatic hyperplasia: 12-month results from the first United States multicenter prospective trial. J Urol. 2004. 172:1404–1408.

25. Ruszat R, Wyler SF, Seitz M, Lehmann K, Abe C, Bonkat G, et al. Comparison of potassium-titanyl-phosphate laser vaporization of the prostate and transurethral resection of the prostate: update of a prospective non-randomized two-centre study. BJU Int. 2008. 102:1432–1438.

26. Tugcu V, Tasci AI, Sahin S, Zorluoglu F. Comparison of photoselective vaporization of the prostate and transurethral resection of the prostate: a prospective nonrandomized bicenter trial with 2-year follow-up. J Endourol. 2008. 22:1519–1525.

27. Spaliviero M, Araki M, Culkin DJ, Wong C. Incidence, management, and prevention of perioperative complications of GreenLight HPS laser photoselective vaporization prostatectomy: experience in the first 70 patients. J Endourol. 2009. 23:495–502.

28. Kim HS, Cho MC, Ku JH, Kim SW, Paick JS. The efficacy and safety of photoselective vaporization of the prostate with a potassium-titanyl-phosphate laser for symptomatic benign prostatic hyperplasia according to prostate size: 2-year surgical outcomes. Korean J Urol. 2010. 51:330–336.

29. Ku JH, Kim SW, Paick JS. Impact of prostate volume on the efficacy of high-power potassium-titanyl-phosphate photoselective vaporization of the prostate: a retrospective, short-term follow-up study on evaluating feasibility and safety. Yonsei Med J. 2010. 51:877–882.

30. Lee CJ, Cho MC, Ku JH, Kim SW, Paick JS. Changes in nocturia after photoselective vaporization of the prostate for patients with benign prostatic hyperplasia. Korean J Urol. 2010. 51:531–536.

31. Malek RS, Kuntzman RS, Barrett DM. Photoselective potassium-titanyl-phosphate laser vaporization of the benign obstructive prostate: observations on long-term outcomes. J Urol. 2005. 174:1344–1348.

32. Hai MA. Photoselective vaporization of prostate: five-year outcomes of entire clinic patient population. Urology. 2009. 73:807–810.

33. Reich O, Bachmann A, Siebels M, Hofstetter A, Stief CG, Sulser T. High power (80 W) potassium-titanyl-phosphate laser vaporization of the prostate in 66 high risk patients. J Urol. 2005. 173:158–160.

34. Bachmann A, Schürch L, Ruszat R, Wyler SF, Seifert HH, Müller A, et al. Photoselective vaporization (PVP) versus transurethral resection of the prostate (TURP): a prospective bi-centre study of perioperative morbidity and early functional outcome. Eur Urol. 2005. 48:965–971.

35. Sandhu JS, Ng C, Vanderbrink BA, Egan C, Kaplan SA, Te AE. High-power potassium-titanyl-phosphate photoselective laser vaporization of prostate for treatment of benign prostatic hyperplasia in men with large prostates. Urology. 2004. 64:1155–1159.

36. Bouchier-Hayes DM, Anderson P, Van Appledorn S, Bugeja P, Costello AJ. KTP laser versus transurethral resection: early results of a randomized trial. J Endourol. 2006. 20:580–585.

37. Chandrasekera S, Muir G. Potassium titanyl phosphate laser prostatectomy: a review. Curr Opin Urol. 2007. 17:22–26.

38. Madersbacher S, Lackner J, Brössner C, Röhlich M, Stancik I, Willinger M, et al. Reoperation, myocardial infarction, and mortality after transurethral and open prostatectomy: a nation-wide, long term analysis of 23,123 cases. Eur Urol. 2005. 47:499–504.

39. Dixon CM. Lasers for the treatment of benign prostatic hyperplasia. Urol clin North Am. 1995. 22:413–422.

40. Chun SS, Razvi HA, Denstedt JD. Laser prostatectomy with the holmium:YAG laser. Tech Urol. 1995. 1:217–221.

41. Gilling PJ, Cass CB, Malcolm AR, Fraundorfer MR. Combination holmium and Nd:YAG laser ablation of the prostate: initial clinical experience. J Endourol. 1995. 9:151–153.

42. Wollin TA, Denstedt JD. The holmium laser in urology. J Clin Laser Med Surg. 1998. 16:13–20.

43. Larizgoitia I, Pons JM. A systematic review of the clinical efficacy and effectiveness of the holmium:YAG laser in urology. BJU Int. 1999. 84:1–9.

44. Gilling PJ, Fraundorfer MR. Holmium laser prostatectomy: a technique in evolution. Curr Opin Urol. 1998. 8:11–15.

45. Kuntz RM, Lehrich K, Ahyai S. Transurethral holmium laser enucleation of the prostate compared with transvesical open prostatectomy: 18-month follow-up of a randomized trial. J Endourol. 2004. 18:189–191.

46. Moody J, Lingeman JE. Holmium laser enucleation for prostate adenoma greater than 100 gm.: comparison to open prostatectomy. J Urol. 2001. 165:459–462.

47. Ruszat R, Seitz M, Wyler SF, Müller G, Rieken M, Bonkat G, et al. Prospective single-centre comparison of 120-W diode-pumped solid-state high-intensity system laser vaporization of the prostate and 200-W high-intensive diode-laser ablation of the prostate for treating benign prostatic hyperplasia. BJU Int. 2009. 104:820–825.

48. Kuo RL, Paterson RF, Siqueira TM Jr, Watkins SL, Simmons GR, Steele RE, et al. Holmium laser enucleation of the prostate: morbidity in a series of 206 patients. Urology. 2003. 62:59–63.

49. Kuo RL, Kim SC, Lingeman JE, Paterson RF, Watkins SL, Simmons GR, et al. Holmium laser enucleation of the prostate (HoLEP): the Methodist hospital experience with greater than 75 gram enucleations. J Urol. 2003. 170:149–152.

50. Elzayat EA, Habib EI, Elhilali MM. Holmium laser enucleation of the prostate: a size-independent new "gold standard". Urology. 2005. 66:5 Suppl. 108–113.

51. Elzayat EA, Elhilali MM. Holmium laser enucleation of the prostate (HoLEP): the endourological alternative to open prostatectomy. Eur Urol. 2006. 49:87–91.

52. Du C, Jin X, Bai F, Qiu Y. Holmium laser enucleation of the prostate: the safety, efficacy, and learning experience in China. J Endourol. 2008. 22:1031–1036.

53. Gilling P. Holmium laser enucleation of the prostate (HoLEP). BJU Int. 2008. 101:131–142.

54. Ahyai SA, Lehrich K, Kuntz RM. Holmium laser enucleation versus transurethral resection of the prostate: 3-year follow-up results of a randomized clinical trial. Eur Urol. 2007. 52:1456–1463.

55. Kuntz RM, Lehrich K, Ahyai SA. Holmium laser enucleation of the prostate versus open prostatectomy for prostates greater than 100 grams: 5-year follow-up results of a randomized clinical trial. Eur Urol. 2008. 53:160–166.

56. Naspro R, Suardi N, Salonia A, Scattoni V, Guazzoni G, Colombo R, et al. Holmium laser enucleation of the prostate versus open prostatectomy for prostates >70 g: 24-month follow-up. Eur Urol. 2006. 50:563–568.

57. Wilson LC, Gilling PJ, Williams A, Kennett KM, Frampton CM, Westenberg AM, et al. A randomized trial comparing holmium laser enucleation versus transurethral resection in the treatment of prostates larger than 40 grams: results at 2 years. Eur Urol. 2006. 50:569–573.

58. Gupta N, Sivaramakrishna , Kumar R, Dogra PN, Seth A. Comparison of standard transurethral resection, transurethral vapour resection and holmium laser enucleation of the prostate for managing benign prostatic hyperplasia of >40g. BJU Int. 2006. 97:85–89.

59. Naspro R, Bachmann A, Gilling P, Kuntz R, Madersbacher S, Montorsi F, et al. A review of the recent evidence (2006-2008) for 532-nm photoselective laser vaporization and holmium laser enucleation of the prostate. Eur Urol. 2009. 55:1345–1357.

60. Vavassori I, Hurle R, Vismara A, Manzetti A, Valenti S. Holmium laser enucleation of the prosate combined with mechanical morcellation: two years of experience with 196 patients. J Endourol. 2004. 18:109–112.

61. Peterson MR, Matlaga BR, Kim SC, Kuo RL, Soergel TM, Watkins SL, et al. Holmium laser enucleation of the prostate for men with urinary retention. J Urol. 2005. 174:998–1001.

62. Shah HN, Kausik V, Hegde S, Shah JN, Bansal MB. Evaluation of fluid absorption during holmium laser enucleation of prostate by breath ethanol technique. J Urol. 2006. 175:537–540.

63. Fried NM, Murray KE. High-power thulium fiber laser ablation of urinary tissues at 1.94 microm. J Endourol. 2005. 19:25–31.

64. Bach T, Herrmann TR, Ganzer R, Burchardt M, Gross AJ. RevoLix vaporesection of the prostate: initial results of 54 patients with an 1-year follow-up. World J Urol. 2007. 25:257–262.

65. Bach T, Herrmann TR, Ganzer R, Blana A, Burchardt M, Gross AJ. Thulium:YAG vaporesection of the prostate: first results. Urologe A. 2009. 48:529–534.

66. Bach T, Wendt-Nordahl G, Michel MS, Herrmann TR, Gross AJ. Feasibility and efficacy of Thulium: YAG laser enucleation (VapoEnucleation) of the prostate. World J Urol. 2009. 27:541–545.

67. Bach T, Herrmann TR, Haecker A, Michel MS, Gross A. Thulium:yttrium-aluminium-garnet laser prostatectomy in men with refractory urinary retention. BJU Int. 2009. 104:361–364.

68. Bach T, Netsch CH, Haecker A, Michel MS, Herrmann TR, Gross AJ. Thulium:YAG laser enucleation (VapoEnucleation) of the prostate: safety and durability during intermediate-term follow-up. World J Urol. 2010. 28:39–43.

69. Gordon S, Watson G. Thulium laser enucleation of the prostate. Eur Urol. 2006. 5:Suppl. 310.

70. Mattioli S, Munoz R, Recasens R, Berbegal C, Cortada J, Urmeneta JM, et al. Treatment of benign prostatic hyperplasia with the Revolix laser. Arch Esp Urol. 2008. 61:1037–1043.

71. Seitz M, Ruszat R, Bayer T, Tilki D, Bachmann A, Stief C, et al. Ex vivo and in vivo investigations of the novel 1,470 nm diode laser for potential treatment of benign prostatic enlargement. Lasers Med Sci. 2009. 24:419–424.

72. Leonardi R. Preliminary results on selective light vaporization with the side-firing 980 nm diode laser in benign prostatic hyperplasia: an ejaculation sparing technique. Prostate Cancer Prostatic Dis. 2009. 12:277–280.

73. Chiang PH, Chen CH, Kang CH, Chuang YC. GreenLight HPS laser 120-W versus diode laser 200-W vaporization of the prostate: comparative clinical experience. Lasers Surg Med. 2010. 42:624–629.